Do novel drugs for diabetes help in COVID-19? Another brick in the wall?
作者信息
Krejner-Bienias Alicja, Grzela Katarzyna, Grzela Tomasz
机构信息
Department of Histology and Embryology, Medical University of Warsaw, Poland.
Department of Pediatric Pulmonology and Allergology, Medical University of Warsaw, Poland.
出版信息
J Diabetes. 2020 Sep;12(9):703-704. doi: 10.1111/1753-0407.13050. Epub 2020 May 22.
Abstract
摘要
相似文献
1
Do novel drugs for diabetes help in COVID-19? Another brick in the wall?治疗糖尿病的新型药物对新冠病毒肺炎有帮助吗？是又一个难题吗？
J Diabetes. 2020 Sep;12(9):703-704. doi: 10.1111/1753-0407.13050. Epub 2020 May 22.
2
COVID-19 and diabetes: Can DPP4 inhibition play a role?2019冠状病毒病与糖尿病：二肽基肽酶4抑制作用能否发挥作用？
Diabetes Res Clin Pract. 2020 Apr;162:108125. doi: 10.1016/j.diabres.2020.108125. Epub 2020 Mar 26.
3
Is the type of diabetes treatment relevant to outcome of COVID-19?糖尿病治疗类型与新型冠状病毒肺炎的预后有关吗？
J Diabetes. 2020 Jul;12(7):486-487. doi: 10.1111/1753-0407.13047.
4
COVID-19 and Diabetes: The Importance of Controlling RAGE.2019冠状病毒病与糖尿病：控制晚期糖基化终末产物受体的重要性
Front Endocrinol (Lausanne). 2020 Jul 14;11:526. doi: 10.3389/fendo.2020.00526. eCollection 2020.
5
[Not Available].[无可用内容]
Rev Med Suisse. 2020 Mar 11;16(685):510-511.
6
Sitagliptin Repositioning in SARS-CoV-2: Effects on ACE-2, CD-26, and Inflammatory Cytokine Storms in the Lung.西他列汀在新型冠状病毒肺炎中的重新定位：对肺部血管紧张素转换酶2、二肽基肽酶4和炎症细胞因子风暴的影响
Iran J Allergy Asthma Immunol. 2020 May 17;19(S1):10-12. doi: 10.18502/ijaai.v19i(s1.r1).2849.
7
Is DPP4 inhibition a comrade or adversary in COVID-19 infection.DPP4 抑制剂在 COVID-19 感染中是战友还是敌人。
Diabetes Res Clin Pract. 2020 Jun;164:108216. doi: 10.1016/j.diabres.2020.108216. Epub 2020 May 19.
8
Importance of Environmental Factors on Production of Computationally- Defined Natural Molecules against COVID-19 Pandemic.环境因素对针对新冠疫情生成计算定义的天然分子的重要性。
Curr Top Med Chem. 2020;20(22):1958-1961. doi: 10.2174/156802662022200917110430.
9
The challenges and benefits of online teaching about diabetes during the COVID-19 pandemic.2019年冠状病毒病疫情期间糖尿病在线教学的挑战与益处。
Diabetes Metab Syndr. 2020 Jul-Aug;14(4):575-576. doi: 10.1016/j.dsx.2020.04.043. Epub 2020 May 11.
10
Dexamethasone nanomedicines for COVID-19.用于治疗新冠肺炎的地塞米松纳米药物。
Nat Nanotechnol. 2020 Aug;15(8):622-624. doi: 10.1038/s41565-020-0752-z.
引用本文的文献
1
Revolutionizing Treatment Strategies for Autoimmune and Inflammatory Disorders: The Impact of Dipeptidyl-Peptidase 4 Inhibitors.革新自身免疫性和炎性疾病的治疗策略：二肽基肽酶4抑制剂的影响
J Inflamm Res. 2024 Mar 23;17:1897-1917. doi: 10.2147/JIR.S442106. eCollection 2024.
2
Is the composition of exhaled breath condensate a key to explain the course of COVID-19 in children?呼出气冷凝物的成分是解释儿童新冠病毒感染疾病病程的关键吗？
Postepy Dermatol Alergol. 2021 Dec;38(6):1001-1005. doi: 10.5114/ada.2020.97395. Epub 2020 Nov 12.
3
Therapy of Type 2 Diabetes in Patients with SARS-CoV-2 Infection.新型冠状病毒感染合并 2 型糖尿病患者的治疗。
Int J Mol Sci. 2021 Jul 16;22(14):7605. doi: 10.3390/ijms22147605.
4
Docking-based virtual screening studies aiming at the covalent inhibition of SARS-CoV-2 M by targeting the cysteine 145.基于对接的虚拟筛选研究旨在通过靶向 SARS-CoV-2 M 的半胱氨酸 145 来实现对其共价抑制。
Comput Biol Chem. 2021 Jun;92:107463. doi: 10.1016/j.compbiolchem.2021.107463. Epub 2021 Feb 20.
5
DPP4 Inhibitors and COVID-19-Holy Grail or Another Dead End?DPP4 抑制剂与 COVID-19：圣杯还是死胡同？
Arch Immunol Ther Exp (Warsz). 2021 Feb 2;69(1):1. doi: 10.1007/s00005-020-00602-5.
本文引用的文献
1
Molecular immune pathogenesis and diagnosis of COVID-19.新型冠状病毒肺炎的分子免疫发病机制与诊断
J Pharm Anal. 2020 Apr;10(2):102-108. doi: 10.1016/j.jpha.2020.03.001. Epub 2020 Mar 5.
2
SARS-CoV-2 Infection in Children.儿童感染新型冠状病毒2型
N Engl J Med. 2020 Apr 23;382(17):1663-1665. doi: 10.1056/NEJMc2005073. Epub 2020 Mar 18.
3
Epidemiology of COVID-19 Among Children in China.中国儿童 COVID-19 流行病学。
Pediatrics. 2020 Jun;145(6). doi: 10.1542/peds.2020-0702. Epub 2020 Mar 16.
4
The pharmacokinetics and pharmacodynamics of alogliptin in children, adolescents, and adults with type 2 diabetes mellitus.阿格列汀在2型糖尿病儿童、青少年及成人中的药代动力学和药效学。
Eur J Clin Pharmacol. 2017 Mar;73(3):279-288. doi: 10.1007/s00228-016-2175-1. Epub 2016 Dec 20.
5
Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome.二肽基肽酶 4 是一种新型脂肪因子，可能将肥胖与代谢综合征联系起来。
Diabetes. 2011 Jul;60(7):1917-25. doi: 10.2337/db10-1707. Epub 2011 May 18.
Zotero 插件